sar425899 dual agonist glp-1 glucagon sanofi Frontiers GLP-1 medications, or glucagon-like peptide-1

GLP-1 RA use in complicated diabetes: There is no clear evidence regarding the use of GLP-1 RA in acute myocardial infarction, although the use of these agents is encouraged in patients with asymptomatic and stable coronary artery disease (CAD)

Barreling into March 2025 and as states start to pull together their own budgets, Colorado is not the only state considering pulling back or in some way limiting their coverage either through state employee health plans or in Medicaid of GLP-1s for treating obesity

doi: 10.1016/j.bone.2024.117338 20 WuZDengWYeYXuJHanDZhengYet al

doi: 10.1124/pr.108.000604 [DOI] [PMC free article] [PubMed] [Google Scholar] 8

A.NewtonS

Psychiatry 66, 6372